Compugroup Medical SE (COP) Given a €56.00 Price Target at Warburg Research

Warburg Research set a €56.00 ($65.88) price target on Compugroup Medical SE (ETR:COP) in a research note published on Wednesday. The firm currently has a buy rating on the stock.

Other equities research analysts have also recently issued research reports about the company. Deutsche Bank AG set a €60.00 ($70.59) target price on Compugroup Medical SE and gave the stock a buy rating in a research note on Thursday, August 24th. Baader Bank set a €52.00 ($61.18) target price on Compugroup Medical SE and gave the stock a buy rating in a research note on Friday, July 21st. Finally, Berenberg Bank set a €53.00 ($62.35) target price on Compugroup Medical SE and gave the stock a neutral rating in a research note on Friday, August 4th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The company presently has an average rating of Buy and an average price target of €56.40 ($66.35).

Compugroup Medical SE (ETR:COP) traded down 1.978% during trading on Wednesday, reaching €47.918. The company had a trading volume of 200 shares. Compugroup Medical SE has a 52 week low of €36.21 and a 52 week high of €52.80. The firm has a market capitalization of €2.38 billion and a price-to-earnings ratio of 52.369. The company’s 50-day moving average is €48.58 and its 200 day moving average is €48.50.

ILLEGAL ACTIVITY WARNING: This story was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The original version of this story can be viewed at https://www.dispatchtribunal.com/2017/10/26/compugroup-medical-se-cop-given-a-56-00-price-target-at-warburg-research.html.

Compugroup Medical SE Company Profile

CompuGroup Medical Societas Europaea develops and sells software, as well as information technology services for healthcare sector worldwide. It operates through three segments: Health Provider Services I, Health Provider Services II, and Health Connectivity Services. The company is involved in the development and sale of practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician’s networks; and integral clinical, administrative, and financial software applications for pharmacies and mail order pharmacies.

Analyst Recommendations for Compugroup Medical SE (ETR:COP)

Receive News & Ratings for Compugroup Medical SE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugroup Medical SE and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply